COMPARATIVE ANALYSIS OF MEASURED FACTOR VIII LEVELS IN SHORT AND LONG ACTING RECOMBINANT FACTOR VIII PRODUCTS

被引：0
|
作者：
Evans, Matthew S. [1 ]
Sanders, Jeffrey C. [1 ]
Eyster, M. Elaine [1 ]
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F15
引用
收藏
页码：E402 / E403
页数：2
相关论文
共 50 条
  • [21] THE PROPERTIES OF FACTOR-VIII IN THE RECOMBINANT FACTOR-VIII CONCENTRATES
    TANAKA, I
    YOSHIOKA, A
    SHIMA, M
    FUJIWARA, T
    TERADA, S
    NAKAI, H
    SAWAMOTO, Y
    KAMISUE, S
    FUKUI, H
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 209 - 209
  • [22] Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
    Lin, Y
    Yang, X
    Chevrier, MC
    Craven, S
    Barrowcliffe, TW
    Lemieux, R
    Ofosu, FA
    HAEMOPHILIA, 2004, 10 (05) : 459 - 469
  • [23] Comparative stability of plasma derived and recombinant factor VIII
    Mankarious, S
    Parti, R
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2077 - P2077
  • [24] Recombinant Factor VIII Concentrates
    Franchini, Massimo
    Lippi, Giuseppe
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (05): : 493 - 497
  • [25] EFFICACY AND SAFETY OF RECOMBINANT FACTOR VIII PRODUCTS IN PATIENTS WITH HEMOPHILIA A
    Musso, Robert
    DRUGS OF TODAY, 2008, 44 (10) : 735 - 750
  • [26] Preclinical safety of a longer acting recombinant factor VIII (BAX 855)
    Dietrich, B.
    Horling, F.
    Spatzenegger, M.
    Piskernik, C.
    Wolfsegger, M.
    Ehrlich, H. J.
    Scheiflinger, F.
    Schwarz, H. P.
    Reipert, B. M.
    Muchitsch, E. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 844 - 844
  • [27] Defining 'full-length' recombinant factor VIII: a comparative structural analysis
    Jankowski, M. A.
    Patel, H.
    Rouse, J. C.
    Marzilli, L. A.
    Weston, S. B.
    Sharpe, P. J.
    HAEMOPHILIA, 2007, 13 (01) : 30 - 37
  • [28] Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factor VIII Fc fusion protein and conventional recombinant factor VIII products
    Iorio, A.
    Krishnan, S.
    Myren, K. J.
    Lethagen, S.
    Mccormick, N.
    Yermakov, S.
    Karner, P.
    HAEMOPHILIA, 2017, 23 (03) : 408 - 416
  • [29] Guidance for establishing a factor VIII testing protocol for the myriad of factor VIII products
    Marlar, Richard A.
    Gausman, Jana N.
    Rollins-Raval, Marian A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (02) : 414 - 423
  • [30] Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII
    Barrow, R. T.
    Lollar, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) : 2223 - 2229
12345